176 related articles for article (PubMed ID: 25630554)
41. Risk of non-small cell lung cancer and the cytochrome P4501A1 Ile462Val polymorphism.
Larsen JE; Colosimo ML; Yang IA; Bowman R; Zimmerman PV; Fong KM
Cancer Causes Control; 2005 Jun; 16(5):579-85. PubMed ID: 15986113
[TBL] [Abstract][Full Text] [Related]
42. CYP1A1 gene polymorphisms increase lung cancer risk in a high-incidence region of Spain: a case control study.
San Jose C; Cabanillas A; Benitez J; Carrillo JA; Jimenez M; Gervasini G
BMC Cancer; 2010 Aug; 10():463. PubMed ID: 20804547
[TBL] [Abstract][Full Text] [Related]
43. Does cytochrome P450 1A1 MspI polymorphism increase acute lymphoblastic leukemia risk? Evidence from 2013 cases and 2903 controls.
Zhuo W; Zhang L; Qiu Z; Zhu B; Chen Z
Gene; 2012 Nov; 510(1):14-21. PubMed ID: 22964275
[TBL] [Abstract][Full Text] [Related]
44. CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a North Indian population.
Sobti RC; Sharma S; Joshi A; Jindal SK; Janmeja A
Biomarkers; 2003; 8(5):415-28. PubMed ID: 14602525
[TBL] [Abstract][Full Text] [Related]
45. Impact of CYP1A1 Polymorphisms on Susceptibility to Chronic Obstructive Pulmonary Disease: A Meta-Analysis.
Wang CD; Chen N; Huang L; Wang JR; Chen ZY; Jiang YM; He YZ; Ji YL
Biomed Res Int; 2015; 2015():942958. PubMed ID: 26425562
[TBL] [Abstract][Full Text] [Related]
46. [Prevention of renal carcinoma: the nutri-genetic approach].
Junien C; Dupret JM; Gallou C; Longuemaux S; Richard S; Saquet C; Krishnamoorty R; Delomenie C; Droz D; Bouvier R; Chauveau D; Joly D; Grunfeld JP; Chretien Y; Mejean A; Beroud C
J Soc Biol; 2000; 194(1):29-38. PubMed ID: 11107547
[TBL] [Abstract][Full Text] [Related]
47. Associations of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens.
Le Marchand L; Sivaraman L; Pierce L; Seifried A; Lum A; Wilkens LR; Lau AF
Cancer Res; 1998 Nov; 58(21):4858-63. PubMed ID: 9809991
[TBL] [Abstract][Full Text] [Related]
48. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: impact of smoking status and CYP1A1, aryl hydrocarbon receptor, and glutathione S-transferase M1 genetic polymorphisms.
Smith GB; Harper PA; Wong JM; Lam MS; Reid KR; Petsikas D; Massey TE
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):839-53. PubMed ID: 11489750
[TBL] [Abstract][Full Text] [Related]
49. Smoking status modifies the relation between CYP1A1*2C gene polymorphism and idiopathic male infertility: the importance of gene-environment interaction analysis for genetic studies of the disease.
Yarosh SL; Kokhtenko EV; Starodubova NI; Churnosov MI; Polonikov AV
Reprod Sci; 2013 Nov; 20(11):1302-7. PubMed ID: 23548414
[TBL] [Abstract][Full Text] [Related]
50. The correlation of combined OGG1, CYP1A1 and GSTP1 gene variants and risk of lung cancer of male Iraqi waterpipe tobacco smokers.
Kudhair BK; Alabid NN; Zayed KS; Lafta IJ; Taheri-Kafrani A
Mol Biol Rep; 2020 Jul; 47(7):5155-5163. PubMed ID: 32577993
[TBL] [Abstract][Full Text] [Related]
51. Polymorphisms of cytochrome P450 1A1, cigarette smoking and risk of coronary artery disease.
Yeh CC; Sung FC; Kuo LT; Hsu WP; Chu HY
Mutat Res; 2009 Jul; 667(1-2):77-81. PubMed ID: 19563927
[TBL] [Abstract][Full Text] [Related]
52. Quantitative assessment of CYP1A1*2A variations with oral carcinoma susceptibility: evidence from 1,438 cases and 2,086 controls.
Zhuo X; Zhao H; Chang A; Zhou Y; Zhang G; Song Y; Tan Y
Cancer Invest; 2012 Oct; 30(8):552-9. PubMed ID: 22909097
[TBL] [Abstract][Full Text] [Related]
53. Cytochrome P450 1A1 (CYP1A1) gene polymorphisms and cervical cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP; Choussein S; Vlahos NF
Mol Biol Rep; 2012 Jun; 39(6):6647-54. PubMed ID: 22294106
[TBL] [Abstract][Full Text] [Related]
54. Relevance of glutathione S-transferase M1 and cytochrome P450 1A1 genetic polymorphisms to the development of head and neck cancers.
Reszka E; Czekaj P; Adamska J; Wasowicz W
Clin Chem Lab Med; 2008; 46(8):1090-6. PubMed ID: 18590468
[TBL] [Abstract][Full Text] [Related]
55. The Cytochrome P4501A1 gene polymorphisms and idiopathic male infertility risk: a meta-analysis.
Fang J; Wang S; Wang H; Zhang S; Su S; Song Z; Deng Y; Qian J; Gu J; Liu B; Cao J; Wang Z
Gene; 2014 Feb; 535(2):93-6. PubMed ID: 24316127
[TBL] [Abstract][Full Text] [Related]
56. Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.
Yao L; Yu X; Yu L
Breast Cancer Res Treat; 2010 Jul; 122(2):503-7. PubMed ID: 20052535
[TBL] [Abstract][Full Text] [Related]
57. CYP1A1 MspI Polymorphism and Cervical Carcinoma Risk in the Multi-Ethnic Population of Malaysia: a Case-Control Study.
Tan YH; Sidik SM; Syed Husain SN; Lye MS; Chong PP
Asian Pac J Cancer Prev; 2016; 17(1):57-64. PubMed ID: 26838255
[TBL] [Abstract][Full Text] [Related]
58. Association of CYP1A1 MspI polymorphism in the esophageal cancer risk: a meta-analysis in the Chinese population.
Zheng H; Zhao Y
Eur J Med Res; 2015 Mar; 20(1):46. PubMed ID: 25886559
[TBL] [Abstract][Full Text] [Related]
59. A case-control study of CYP2E1 (PstI) and CYP1A1 (MspI) polymorphisms in colorectal cancer.
Proença MA; Fernandes GM; Russo A; Lelis RB; Netinho JG; Cunrath GS; Silva AE; Goloni-Bertollo EM; Pavarino EC
Genet Mol Res; 2015 Dec; 14(4):17856-63. PubMed ID: 26782431
[TBL] [Abstract][Full Text] [Related]
60. Lung cancer risk in relation to nicotinic acetylcholine receptor, CYP2A6 and CYP1A1 genotypes in the Bangladeshi population.
Islam MS; Ahmed MU; Sayeed MS; Maruf AA; Mostofa AG; Hussain SM; Kabir Y; Daly AK; Hasnat A
Clin Chim Acta; 2013 Feb; 416():11-9. PubMed ID: 23178447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
